In-silico screening and molecular docking studies of active constituents of Withania somnifera to investigate its kinase inhibitory activities. (2022). Journal of Pharmaceutical Negative Results, 13(4), 1342-1349. https://doi.org/10.47750/pnr.2022.13.04.187